Successful renal transplantation in a patient with atypical hemolytic uremic syndrome carrying mutations in both factor i and MCP

American Journal of Transplantation

Volumn 9, Issue 6, 2009, Pages 1477-1483

  Cruzado, J M ^a   De Córdoba, S Rodríguez ^b   Melilli, E ^c   Bestard, O ^a   Rama, I ^a   Sanchez Corral P ^d   Lopez Trascasa M ^d   Navarro, I ^a   Torras, J ^a   Goma M ^a   Grinyo J M ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^c Policlinico Universitario gB Rossi   (Italy)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Antibody mediated rejection; Complement regulation; Hemolytic uremic syndrome; Kidney transplantation

Indexed keywords

COMPLEMENT FACTOR H; FIBRINOGEN; MEMBRANE COFACTOR PROTEIN;

ADULT; ARTICLE; ATYPICAL HEMOLYTIC UREMIC SYNDROME; CASE REPORT; CFH GENE; CFI GENE; COMPLEMENT ACTIVATION; GENE; GENE MUTATION; GRAFT REJECTION; HEMOLYTIC UREMIC SYNDROME; HETEROZYGOSITY; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MICROANGIOPATHY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTIGENS, CD46; COMPLEMENT FACTOR I; GRAFT REJECTION; HEMOLYTIC-UREMIC SYNDROME; HUMANS; KIDNEY TRANSPLANTATION; MALE; MUTATION;

EID: 66249101956     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02647.x     Document Type: Article

References (31)

1. Caprioli J, Peng L, Remuzzi G. The hemolytic uremic syndromes. Curr Opin Crit Care 2005 11 : 487 492. (Pubitemid 41482706)
2. Bresin E, Dain E, Noris M et al. Outcome of patients with non-shiga Toxin-associated HUS: Prognostic significance of genetic background. Clin J Am Soc Nephrol 2006 1 : 88 99.
3. Caprioli J, Bettinaglio P, Zipfel PF et al. The molecular basis of familial hemolytic uremic syndrome: Mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. J Am Soc Nephrol 2001 12 : 297 307. (Pubitemid 32116371)
4. Caprioli J, Castelletti F, Bucchioni S et al. Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: The C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Hum Mol Genet 2003 12 : 3385 3395. (Pubitemid 37541083)
5. Manuelian T, Hellwage J, Meri S et al. Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. J Clin Invest 2003 111 : 1181 1190. (Pubitemid 36519935)
6. Pérez-Caballero D, González-Rubio C, Esther Gallardo M et al. Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. Am J Hum Genet 2001 68 : 478 484. (Pubitemid 32147816)
7. Richards A, Buddles M, Donne R et al. Factor H mutations in hemolytic uremic syndrome cluster in exons 1820, a domain important for host cell recognition. Am J Hum Genet 2001 68 : 485 490. (Pubitemid 32147817)
8. Venables JP, Strain L, Routledge D et al. Atypical haemolytic uraemic syndrome associated with a hybrid complement gene. PLoS Med 2006 3 : 836 844.
9. Warwicker P, Goodship THJ, Donne RL et al. Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int 1998 53 : 836 844. (Pubitemid 28155655)
10. Esparza-Gordillo J, Goicoechea de Jorge E, Buil A et al. Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32. Hum Mol Genet 2005 14 : 703 712. (Pubitemid 40309595)
11. Fremeaux-Bacchi V, Kemp EJ, Goodship JA et al. The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: Evidence from two independent cohorts. J Med Genet 2005 42 : 852 856. (Pubitemid 41598193)
12. Noris M, Brioschi S, Caprioli J et al. Familial haemolytic uraemic syndrome and an MCP mutation. Lancet 2003 362 : 1542 1547. (Pubitemid 37410193)
13. Richards A, Kemp EJ, Liszewski MK et al. Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci U S A 2003 100 : 12966 12971. (Pubitemid 37340009)
14. Fremeaux-Bacchi V, Dragon-Durey MA, Blouin J et al. Complement factor I: A susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet 2004 41 : e84.
15. Kavanagh D, Kemp EJ, Mayland E et al. Mutations in complement Factor I predispose to development of atypical hemolytic uremic syndrome. J Am Soc Nephrol 2005 16 : 2150 2155. (Pubitemid 41716447)
16. Goicoechea de Jorge E, Harris CL, Esparza-Gordillo J et al. Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc Natl Acad Sci U S A 2007 104 : 240 245. (Pubitemid 46068016)
17. Frémeaux-Bacchi V, Miller EC, Liszewski MK et al. Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood 2008 112 : 4948 4952.
18. Sánchez-Corral P, Pérez-Caballero D, Huarte O et al. Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome. Am J Hum Genet 2002 71 : 1285 1295. (Pubitemid 36015883)
19. Saland JM, Ruggenenti P, Remuzzi G. Consensus Study Group. Liver-kidney transplantation to cure atypical hemolytic uremic syndrome. J Am Soc Nephrol 2008 [Epub ahead of print].
20. Remuzzi G, Ruggenenti P, Codazzi D et al. Combined kidney and liver transplantation for familial haemolytic uraemic syndrome. Lancet 2002 359 : 1671 1672. (Pubitemid 34518531)
21. Fremeaux-Bacchi V, Moulton EA, Kavanagh D et al. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J Am Soc Nephrol 2006 17 : 2017 2025. (Pubitemid 44036186)
22. Esparza-Gordillo J, Goicoechea de Jorge E, Garrido CA et al. Insights into hemolytic uremic syndrome: Segregation of three independent predisposition factors in a large, multiple affected pedigrees. Mol Immunol 2006 43 : 1769 1775.
23. Zipfel PF, Edey M, Heinen S et al. Deletion of complement factor H related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome. PLoS Genet 2007 3 : e41.
24. Bestard O, Cruzado JM, Mestre M et al. Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates. J Immunol 2007 179 : 4901 4909.
25. Pickering MC, Goicoechea de Jorge E, Martinez-Barricarte R et al. Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains. J Exp Med 2007 204 : 1249 1256. (Pubitemid 46919861)
26. Seitz B, Albano L, Vocila F et al. Recurrence of hemolytic uremic syndrome after renal transplantation. Transplant Proc 2007 39 : 2583 2585. (Pubitemid 47588386)
27. Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA et al. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol 2007 18 : 2392 2400. (Pubitemid 47203855)
28. Rodríguez de Córdoba S, Goicoechea de Jorge E. Translational mini-review series on complement factor H: Genetics and disease associations of human complement factor H. Clin Exp Immunol 2008 151 : 1 13.
29. Ponce-Castro IM, González-Rubio C, Delgado-Cerviño EM et al. Molecular characterization of complement factor I deficiency in two Spanish families. Mol Immunol 2008 45 : 2764 2771.
30. González-Rubio C, Ferreira-Cerdán A, Ponce IM, Arpa J, Fontán G, López-Trascasa M. Complement factor I deficiency associated with recurrent meningitis coinciding with menstruation. Arch Neurol 2001 58 : 1923 1928. (Pubitemid 33044263)
31. Oyen O, Strøm EH, Midtvedt K et al. Calcineurin inhibitor-free immunosuppression in renal allograft recipients with thrombotic microangiopathy/hemolytic uremic syndrome. Am J Transplant 2006 6 : 412 418. (Pubitemid 43382180)